Skip to main content
SpringerLink
Log in

Usefulness of presepsin in the diagnosis of sepsis in a multicenter prospective study

  • Original Article
  • Published:
Journal of Infection and Chemotherapy

Abstract

The clinical usefulness of presepsin for discriminating between bacterial and nonbacterial infections (including systemic inflammatory response syndrome) was studied and compared with procalcitonin (PCT) and interleukin-6 (IL-6) in a multicenter prospective study. Suspected sepsis patients (n = 207) were enrolled into the study. Presepsin levels in patients with systemic bacterial infection and localized bacterial infection were significantly higher than in those with nonbacterial infections. In addition, presepsin, PCT, and IL-6 levels in patients with bacterial infectious disease were significantly higher than in those with nonbacterial infectious disease (P < 0.0001, P < 0.0001, and P < 0.0001, respectively). The area under the receiver operating characteristic curve was 0.908 for presepsin, 0.905 for PCT, and 0.825 for IL-6 in patients with bacterial infectious disease and those with nonbacterial infectious disease. The cutoff value of presepsin for discrimination of bacterial and nonbacterial infectious diseases was determined to be 600 pg/ml, of which the clinical sensitivity and specificity were 87.8 % and 81.4 %, respectively. Presepsin levels did not differ significantly between patients with gram-positive and gram-negative bacterial infections. The sensitivity of blood culture was 35.4 %; that for presepsin was 91.9 %. Also there were no significant differences in presepsin levels between the blood culture-positive and -negative groups. Consequently, presepsin is useful for the diagnosis of sepsis, and it is superior to conventional markers and blood culture.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Meisner M. Pathobiochemistry and clinical use of procalcitonin. 2002;323(1-2):17–29.

    CAS  Google Scholar 

  2. Aikawa N, Fujishima S, Endo S, Sekine I, Kogawa K, Yamamoto Y, et al. Multicenter prospective study of procalcitonin as an indicator of sepsis. J Infect Chemother. 2005;11:152–9.

    Article  PubMed  CAS  Google Scholar 

  3. Endo S, Aikawa N, Fujishima S, Sekine I, Kogawa K, Yamamoto Y, et al. Usefulness of procalcitonin serum level for the discrimination of severe sepsis from sepsis: a multicenter prospective study. J Infect Chemother. 2008;14:244–9.

    Article  PubMed  CAS  Google Scholar 

  4. Endo S, Sato N, Suzuki Y, Kojika M, Takahashi G, Yamada Y, et al. Significance of measuring procalcitonin values for diagnosis of sepsis. J Jpn Soc Surg Infect 2007;4(3):112–120 (in Japanese)

    Google Scholar 

  5. Furusako S, Shirakawa K. Methods for detecting human low molecular weight CD14. United States patent 2008; US7465547 B2.

  6. Furusako S, Shirakawa K, Hirose J. Soluble CD14 antigen. United States patent 2009; US7608684 B2.

  7. Naitoh K, Shirakawa K, Hirose J, Nakamura M, Takeuchi T, Hosaka Y, et al. The new sepsis marker, sCD14-ST (PRESEPSIN): induction mechanism in the rabbit sepsis models. SEPSIS 2010, Poster P-19.

  8. Nakamura M, Takeuchi T, Naito K, Shirakawa K, Hosaka Y, Yamasaki F, et al. Early elevation of plasma soluble CD14 subtype, a novel biomarker for sepsis, in a rabbit cecal ligation and puncture model. Crit Care. 2008;12(suppl 2):P194. doi:10.1186/cc6415.

    Article  Google Scholar 

  9. Yaegashi Y, Shirakawa K, Sato N, Suzuki Y, Kojika M, Imai S, et al. Evaluation of a newly identified soluble CD14 subtype as a marker for sepsis. J Infect Chemother. 2005;11(5):234–8.

    Article  PubMed  CAS  Google Scholar 

  10. Kojika M, Takahashi G, Matsumoto N, Kikkawa T, Hoshikawa K, Shioya N, et al. Serum levels of soluble CD14 subtype reflect the APACHE II and SOFA Scores. Med Postgrad. 2010;48(1):46–50.

    Google Scholar 

  11. Takahashi G, Suzuki Y, Kojika M, Matsumoto N, Shozushima T, Makabe H, et al. Evaluation of responses to IVIG therapy in patients with severe sepsis and septic shock by soluble CD14 subtype monitoring. Med Postgrad. 2010;48(1):19–24.

    Google Scholar 

  12. Shozushima T, Takahashi G, Matsumoto N, Kojika M, Okamura Y, Endo S. Usefulness of presepsin (sCD14-ST) measurements as a marker for the diagnosis and severity of sepsis that satisfied diagnostic criteria of systemic inflammatory response syndrome. J Infect Chemother. 2011;17(6):764–9.

    Article  PubMed  CAS  Google Scholar 

  13. Bone RC, Balk RA, Cerra FB, Dellinger RP, Fein AM, Knaus WA, et al. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. Chest. 1992;101(6):1644–55.

    Article  PubMed  CAS  Google Scholar 

  14. Kurihara T, Yanagida A, Yokoi H, Koyata A, Matsuya T, Ogawa J, et al. Evaluation of cardiac assays on a benchtop chemiluminescent enzyme immunoassay analyzer, PATHFAST. Anal Biochem. 2008;375(1):144–6.

    Article  PubMed  CAS  Google Scholar 

  15. Okamura Y, Yokoi H. Development of a point-of-care assay system for measurement of presepsin (sCD14-ST). Clin Chim Acta. 2011;412(23–24):2157–61.

    Article  PubMed  CAS  Google Scholar 

  16. Dellinger RP, Levy MM, Carlet JM, Bion J, Parker MM, Jaeschke R, et al. Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2008. Crit Care Med. 2008;36(1):296–327.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Critical Care Medicine, School of Medicine, Iwate Medical University, 19-1 Uchimaru, Morioka, 020-8505, Japan

    Shigeatsu Endo, Yasushi Suzuki, Gaku Takahashi & Tatsuyori Shozushima

  2. Department of Emergency and Critical Care Medicine, Faculty of Medicine, Fukuoka University, Fukuoka, Japan

    Hiroyasu Ishikura, Akira Murai, Takeshi Nishida & Yuhei Irie

  3. Anesthesiology, Emergency and Critical Care Center, Kariya Toyota General Hospital, Kariya, Japan

    Masanao Miura & Hironobu Iguchi

  4. Department of Gastroenterological Surgery, Kochi Health Sciences Center, Kochi, Japan

    Yasuo Fukui, Kimiaki Tanaka & Tsuyoshi Nojima

  5. Research and Development Division, Yachiyo R&D Department, Mitsubishi Chemical Medience Corporation, Tokyo, Japan

    Yoshikazu Okamura

Authors
  1. Shigeatsu Endo
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Yasushi Suzuki
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Gaku Takahashi
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Tatsuyori Shozushima
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Hiroyasu Ishikura
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Akira Murai
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Takeshi Nishida
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Yuhei Irie
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Masanao Miura
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Hironobu Iguchi
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. Yasuo Fukui
    View author publications

    You can also search for this author in PubMed Google Scholar

  12. Kimiaki Tanaka
    View author publications

    You can also search for this author in PubMed Google Scholar

  13. Tsuyoshi Nojima
    View author publications

    You can also search for this author in PubMed Google Scholar

  14. Yoshikazu Okamura
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Shigeatsu Endo.

About this article

Cite this article

Endo, S., Suzuki, Y., Takahashi, G. et al. Usefulness of presepsin in the diagnosis of sepsis in a multicenter prospective study. J Infect Chemother 18, 891–897 (2012). https://doi.org/10.1007/s10156-012-0435-2

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10156-012-0435-2

Keywords

Search

Navigation